New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Tenaya Therapeutics, Inc.
TNYA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

140M

Biotechnology

Next Earning date - 13 Nov 2024

140M

Biotechnology

Next Earning date - 13 Nov 2024

1.77USD
Shape0.13 ( 7.93%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-18%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

75%

Quote Panel

Shape
Updated October 12, 2024
1W 0.00 % 1M -11.50 % 3M -49.72 % 1Y -22.71 %

Key Metrics

Shape
  • Market Cap

    139.63M


  • Shares Outstanding

    78.89M


  • Share in Float

    65.30M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    1.77


  • Average Volume

    394862


  • Beta

    2.357


  • Range

    1.61-7.01


  • Industry

    Biotechnology


  • Website

    https://www.tenayatherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.90x

P/S Ratio

1.13x

P/B Ratio

0.1

Debt/Equity

-683.5%

Net Margin

$-1.5

EPS

How TNYA compares to sector?

P/E Ratio

Relative Strength

Shape

TNYA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5M

ShapeNaN%

2025-Revenue

$1.50

Shape-340%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

William Blair

initialise

Previous: Not converted

2024-06-10

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.74
vs -0.68

Q4.22

arrow
arrow

N/A

-0.61
vs -0.63

Q1.23

arrow
arrow

N/A

-0.43
vs -0.75

Q2.23

arrow
arrow

N/A

-0.45
vs -0.69

Q3.23

arrow
arrow

N/A

-0.39
vs -0.74

Q4.23

arrow
arrow

N/A

-0.40
vs -0.61

Q1.24

arrow
arrow

N/A

-0.40
vs -0.43

Q2.24

arrow
arrow

N/A

-0.34
vs -0.45

Q3.24

arrow
arrow

N/A

-0.37
vs -0.39

Q4.24

arrow
arrow

N/A

-0.40
vs -0.40

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

17.7M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-93%

1.3M  vs 17.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-15%

-0.15
vs -0.13

Q4.22

arrow
arrow

-14%

-0.14
vs -0.15

Q1.23

arrow
arrow

-15%

-0.15
vs -0.14

Q2.23

arrow
arrow

-18%

-0.18
vs -0.15

Q3.23

arrow
arrow

-18%

-0.18
vs -0.18

Q4.23

arrow
arrow

-21%

-0.21
vs -0.18

Q1.24

arrow
arrow

-20%

-0.20
vs -0.21

Q2.24

arrow
arrow

-22%

-0.22
vs -0.20

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

69

69
vs 49

41%

Q4.22

arrow
arrow

69

69
vs 69

NA

Q1.23

arrow
arrow

68

68
vs 69

-1%

Q2.23

arrow
arrow

83

83
vs 68

22%

Q3.23

arrow
arrow

79

79
vs 83

-5%

Q4.23

arrow
arrow

75

75
vs 79

-5%

Q1.24

arrow
arrow

90

90
vs 75

20%

Q2.24

arrow
arrow

96

96
vs 90

7%

Earnings Growth

Latest News